Frontiers in Oncology | Hematologic Malignancies

Case Report

Published on 14 Mar 2025

Next-generation sequencing guides diagnosis and treatment in a complex presentation of ALK-positive anaplastic large-cell lymphoma: a case report

in Hematologic Malignancies

Tejasvini Vaid
Thomas S. Gunning
Rachel Cohen
Alexandra Della Pia
Jason Voss
Melinda Weber
Andrew L. Pecora
Lori A. Leslie
Tatyana Feldman
Andre H. Goy

Frontiers in Oncology

doi 10.3389/fonc.2025.1502782

110 views

Original Research

Published on 13 Mar 2025

The immune cell dynamics in the peripheral blood of cHL patients receiving anti-PD1 treatment

in Hematologic Malignancies

Vanessa Cristaldi
Lodovico Terzi di Bergamo
Lucrezia Patruno
Marinos Kallikourdis
Giada Andrea Cassanmagnago
Francesco Corrado
Eleonora Calabretta
Adalgisa Condoluci
Martina di Trani
Daoud Rahal

Frontiers in Oncology

doi 10.3389/fonc.2025.1518107

179 views

Systematic Review

Accepted on 12 Mar 2025

The Association of FAT1 Mutations with Therapeutic Outcomes in AML, Especially in Receiving Venetoclax Combination

in Hematologic Malignancies

Tao Wang
俊霞黄
Yongqian Jia
Jun-Ting Li
Mou WeiWei
Guang Lu

Frontiers in Oncology

doi 10.3389/fonc.2025.1456832

Systematic Review

Published on 12 Mar 2025

Clinical outcomes associated with anti-CD38-based retreatment in relapsed/refractory multiple myeloma: a systematic literature review

in Hematologic Malignancies

Francesca Gay
Elena Zamagni
Craig Emmitt Cole
Christof Scheid
Malin Hultcrantz
Justyna Chorazy
Ike Iheanacho
Anuja Pandey
Jacopo Bitetti
Natalie Boytsov

Frontiers in Oncology

doi 10.3389/fonc.2025.1550644

396 views

Original Research

Published on 12 Mar 2025

Operational procedure sharing pathway in veno-occlusive disease: a Delphi consensus-based recommendations

in Hematologic Malignancies

Francesca Bonifazi
Federico Ravaioli
Anna Paola Iori
Giuseppe Milone
Attilio Olivieri
Arcangelo Prete
Domenico Russo
Stella Santarone
Simona Sica
Marco Zecca

Frontiers in Oncology

doi 10.3389/fonc.2025.1498782

129 views

Case Report

Accepted on 10 Mar 2025

18F-FDG PET/CT in the Diagnosis and Treatment of Atypical Extensive Skin Lesions in Extranodal NK/T-cell Lymphoma, Nasal Type (ENKTCL-NT): A Case Report

in Hematologic Malignancies

Xu-Sheng Liu
Zhi-Jun Pei

Frontiers in Oncology

doi 10.3389/fonc.2025.1480661

Original Research

Accepted on 10 Mar 2025

Enhancing Acute Promyelocytic Leukaemia Screening with an Artificial Intelligence-Based Digital Morphology Analyser: A Prospective Clinical Evaluation of MC-100i

in Hematologic Malignancies

Fan Zhang
Pingjuan Liu
Jieyu Zhan
Jing Cheng
Hongxia Tan
Jiahang Zhang
Meiqi Song
Fengying Wu
Qiuyi Lin
Zhuangbiao Shi

Frontiers in Oncology

doi 10.3389/fonc.2025.1572838

Case Report

Accepted on 10 Mar 2025

CD20-positive peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) : a case series and review of the literature

in Hematologic Malignancies

Pan Zhou
Lifu Wang
Xiaohang Pei
Liu Yang
Yunmeng Zhou
Rongjun Ma
Yuqing Chen
Zunmin Zhu
Xiaoli Yuan

Frontiers in Oncology

doi 10.3389/fonc.2025.1553969

Brief Research Report

Accepted on 07 Mar 2025

Identification of a Novel NRF1::PDGFRA Fusion in Myeloid/Lymphoid Neoplasms With Eosinophilia and Tyrosine Kinase Gene Fusions

in Hematologic Malignancies

Jialong Liu
Yaqing Feng
Yanfang Zhang
Yingnan Xiao
Xi Liu
Tingting Xiao
Junyan Zou
Kai Fan
Lisha Lu
Xiaoxia Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1552928

Original Research

Published on 07 Mar 2025

Anemia and blood transfusions in myelofibrosis: economic and organizational impact on Italian patients, caregivers and hospitals

in Hematologic Malignancies

Francesca Palandri
Alessandro Inzoli
Antonella Barone
Daniela Dordoni
Elisa Formenti
Giorgio Corradini D’Elia
Victoria Lucia Rabsiun Aramburu
Giuseppe Alberto Palumbo
Massimo Breccia

Frontiers in Oncology

doi 10.3389/fonc.2025.1549023

457 views

Original Research

Published on 06 Mar 2025

Associations of ANGPT2 expression and its variants (rs1868554 and rs7825407) with multiple myeloma risk and outcome

in Hematologic Malignancies

Sylwia Popek-Marciniec
Wojciech Styk
Sylwia Chocholska
Aneta Szudy-Szczyrek
Katarzyna Sidor
Grazyna Swiderska-Kolacz
Marek Hus
Joanna Czerwik-Marcinkowska
Szymon Zmorzynski

Frontiers in Oncology

doi 10.3389/fonc.2025.1468373

216 views

Original Research

Accepted on 05 Mar 2025

Complex causal association between genetically predicted 731 immunocyte phenotype and leukaemia: A bidirectional Two-sample mendelian randomization analysis

in Hematologic Malignancies

Chenyang Fan
Pengying Yuan
Weifeng Zhang
Haijing Chen
Xinli Zhou
Yucheng Zhang
Gengda Zhu
Chengyulong Zheng
Lixiang Yan
Zhexin Shi

Frontiers in Oncology

doi 10.3389/fonc.2025.1435783

Review

Published on 05 Mar 2025

Lipid metabolism in multiple myeloma: pathogenesis, therapeutic opportunities, and future directions

in Hematologic Malignancies

Huiquan Wang
Jiafeng Zhang
Hefei Ren
Lei Chen
Jigang Ren
Chang Liu
Hongkun Wu
Lin Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1531928

234 views

Case Report

Accepted on 04 Mar 2025

Endoscopic Ultrasound-Guided Fine Needle Aspiration in Diagnosing Primary Mediastinal Large B-Cell Lymphoma: A Case Report

in Hematologic Malignancies

Jingyan Tang
Yuchen Guan
Jianfeng Zhang
Chengqi Guan

Frontiers in Oncology

doi 10.3389/fonc.2025.1404211

Correction

Accepted on 03 Mar 2025

Corrigendum: Efficacy and survival outcome of allogeneic stemcell transplantation in multiple myeloma: meta-analysis in the recent 10 years

in Hematologic Malignancies

SiYu Lin
KeJie Lu
XiaoNa Zheng
Jian Hou
TingTing Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1559194

Case Report

Accepted on 03 Mar 2025

Case Report: Decitabine and Venetoclax Sequentially Followed by FLAG-Ida and Venetoclax with Immediate Allogeneic Stem Cell Transplantation in Newly Diagnosed Acute Myeloid Leukemia with Chromosome 3 Inversion/MECOM Rearrangement

in Hematologic Malignancies

Andrius Žučenka
Milvydė Tamutytė

Frontiers in Oncology

doi 10.3389/fonc.2025.1530852

Navigation group

Articles

Next-generation sequencing guides diagnosis and treatment in a complex presentation of ALK-positive anaplastic large-cell lymphoma: a case report

The immune cell dynamics in the peripheral blood of cHL patients receiving anti-PD1 treatment

The Association of FAT1 Mutations with Therapeutic Outcomes in AML, Especially in Receiving Venetoclax Combination

Clinical outcomes associated with anti-CD38-based retreatment in relapsed/refractory multiple myeloma: a systematic literature review

Operational procedure sharing pathway in veno-occlusive disease: a Delphi consensus-based recommendations

18F-FDG PET/CT in the Diagnosis and Treatment of Atypical Extensive Skin Lesions in Extranodal NK/T-cell Lymphoma, Nasal Type (ENKTCL-NT): A Case Report

Enhancing Acute Promyelocytic Leukaemia Screening with an Artificial Intelligence-Based Digital Morphology Analyser: A Prospective Clinical Evaluation of MC-100i

CD20-positive peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) : a case series and review of the literature

Identification of a Novel NRF1::PDGFRA Fusion in Myeloid/Lymphoid Neoplasms With Eosinophilia and Tyrosine Kinase Gene Fusions

Anemia and blood transfusions in myelofibrosis: economic and organizational impact on Italian patients, caregivers and hospitals

Associations of ANGPT2 expression and its variants (rs1868554 and rs7825407) with multiple myeloma risk and outcome

Complex causal association between genetically predicted 731 immunocyte phenotype and leukaemia: A bidirectional Two-sample mendelian randomization analysis

Lipid metabolism in multiple myeloma: pathogenesis, therapeutic opportunities, and future directions

Endoscopic Ultrasound-Guided Fine Needle Aspiration in Diagnosing Primary Mediastinal Large B-Cell Lymphoma: A Case Report

Corrigendum: Efficacy and survival outcome of allogeneic stemcell transplantation in multiple myeloma: meta-analysis in the recent 10 years

Case Report: Decitabine and Venetoclax Sequentially Followed by FLAG-Ida and Venetoclax with Immediate Allogeneic Stem Cell Transplantation in Newly Diagnosed Acute Myeloid Leukemia with Chromosome 3 Inversion/MECOM Rearrangement